Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy
Applied Immunohistochemistry and Molecular Morphology - United States
doi 10.1097/pai.0000000000000292
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)